SIGNAL // LOADING
Loading page
Glossary term
MASLD
Also known as Metabolic dysfunction-associated steatotic liver disease
MASLD is a clinical condition, procedure, or behavior method used in preventive and metabolic care planning.
MASLD is interpreted as part of a full biomarker pattern rather than in isolation. Trends over time and adjacent markers usually matter more than a single draw.
Medically reviewed byDr. Lena Okafor, MD
Medical Director - updated April 2026How we review
External references
Related
Connected context
Related terms
Related guides
Insulin resistance early markers: what shows up before A1c movesSleep architecture basics: REM, deep sleep, and what to optimize firstZone 2 training for metabolic health: the practical protocolNAD and longevity markers: what we know, what's hypeWhat a comprehensive metabolic panel actually tells youPeptides: what they are, what they aren't, and where ALUKARD standsProvider-reviewed care vs DIY supplementation: when each makes senseHormone imbalance: where to start when symptoms overlapFree vs total testosterone: the ratio that actually predicts symptomsFasting insulin and HOMA-IR: the metabolic signal that precedes A1c by years